 Veronica Alaniz
Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anorectal Malformations | 7 | 2023 | 112 | 2.660 |
Why?
| | Vagina | 8 | 2025 | 186 | 2.230 |
Why?
| | Urogenital Abnormalities | 4 | 2025 | 64 | 2.000 |
Why?
| | Gynecology | 6 | 2022 | 168 | 1.810 |
Why?
| | Congenital Abnormalities | 5 | 2025 | 88 | 1.300 |
Why?
| | Transgender Persons | 2 | 2022 | 182 | 1.210 |
Why?
| | Mullerian Ducts | 2 | 2025 | 12 | 1.150 |
Why?
| | Intrauterine Devices, Medicated | 2 | 2024 | 29 | 1.010 |
Why?
| | Endometriosis | 1 | 2024 | 50 | 0.840 |
Why?
| | Abnormalities, Multiple | 1 | 2025 | 188 | 0.830 |
Why?
| | Hymen | 2 | 2022 | 5 | 0.820 |
Why?
| | Leuprolide | 1 | 2022 | 20 | 0.790 |
Why?
| | 46, XX Disorders of Sex Development | 1 | 2022 | 6 | 0.790 |
Why?
| | Contraceptive Agents, Female | 2 | 2024 | 80 | 0.730 |
Why?
| | Vulvar Lichen Sclerosus | 1 | 2020 | 1 | 0.700 |
Why?
| | Vulvovaginitis | 1 | 2020 | 1 | 0.700 |
Why?
| | Kidney | 3 | 2025 | 1467 | 0.690 |
Why?
| | Stents | 1 | 2024 | 528 | 0.660 |
Why?
| | Genital Diseases, Female | 2 | 2019 | 28 | 0.660 |
Why?
| | Gonadal Dysgenesis | 2 | 2017 | 7 | 0.650 |
Why?
| | Disorders of Sex Development | 2 | 2019 | 39 | 0.640 |
Why?
| | Kidney Diseases | 1 | 2023 | 406 | 0.640 |
Why?
| | Symptom Assessment | 1 | 2020 | 128 | 0.640 |
Why?
| | Lichen Sclerosus et Atrophicus | 1 | 2019 | 3 | 0.630 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2022 | 254 | 0.630 |
Why?
| | Colitis, Ulcerative | 1 | 2021 | 137 | 0.620 |
Why?
| | Coitus | 1 | 2019 | 22 | 0.620 |
Why?
| | Urethra | 1 | 2019 | 55 | 0.600 |
Why?
| | Female | 37 | 2025 | 72785 | 0.600 |
Why?
| | Adolescent | 20 | 2025 | 21380 | 0.590 |
Why?
| | Ultrasonography | 2 | 2025 | 750 | 0.560 |
Why?
| | Breast Cyst | 1 | 2017 | 2 | 0.540 |
Why?
| | Young Adult | 13 | 2025 | 13126 | 0.540 |
Why?
| | Mass Screening | 1 | 2025 | 1266 | 0.520 |
Why?
| | Vulvar Diseases | 3 | 2022 | 9 | 0.510 |
Why?
| | Gonads | 1 | 2016 | 23 | 0.510 |
Why?
| | Child | 17 | 2025 | 21816 | 0.500 |
Why?
| | Breast | 1 | 2017 | 149 | 0.500 |
Why?
| | Hyperemesis Gravidarum | 1 | 2015 | 5 | 0.480 |
Why?
| | Practice Patterns, Physicians' | 1 | 2024 | 1300 | 0.480 |
Why?
| | Humans | 37 | 2025 | 136750 | 0.420 |
Why?
| | Cannabinoids | 1 | 2015 | 161 | 0.400 |
Why?
| | Retrospective Studies | 11 | 2025 | 15499 | 0.390 |
Why?
| | Vaginal Diseases | 2 | 2024 | 21 | 0.380 |
Why?
| | Constriction, Pathologic | 2 | 2024 | 242 | 0.370 |
Why?
| | Marijuana Smoking | 1 | 2015 | 249 | 0.370 |
Why?
| | Adolescent Medicine | 2 | 2022 | 30 | 0.360 |
Why?
| | Adult | 13 | 2025 | 37626 | 0.330 |
Why?
| | Pregnancy Outcome | 2 | 2023 | 411 | 0.330 |
Why?
| | Internship and Residency | 4 | 2022 | 1127 | 0.330 |
Why?
| | Cloaca | 2 | 2021 | 48 | 0.320 |
Why?
| | Pediatrics | 3 | 2022 | 1094 | 0.300 |
Why?
| | Child, Preschool | 5 | 2025 | 10997 | 0.260 |
Why?
| | Colorectal Neoplasms | 2 | 2025 | 791 | 0.250 |
Why?
| | Hematometra | 2 | 2023 | 5 | 0.250 |
Why?
| | Gynecologic Surgical Procedures | 3 | 2021 | 63 | 0.240 |
Why?
| | Uterus | 2 | 2023 | 215 | 0.240 |
Why?
| | Ulcer | 2 | 2022 | 32 | 0.240 |
Why?
| | Gonadoblastoma | 1 | 2024 | 6 | 0.220 |
Why?
| | Levonorgestrel | 1 | 2024 | 38 | 0.210 |
Why?
| | Magnetic Resonance Imaging | 1 | 2016 | 3556 | 0.210 |
Why?
| | Hematocolpos | 1 | 2023 | 3 | 0.210 |
Why?
| | Gynecological Examination | 1 | 2022 | 4 | 0.200 |
Why?
| | Pregnancy | 6 | 2023 | 6727 | 0.200 |
Why?
| | Stomatitis, Aphthous | 1 | 2022 | 10 | 0.200 |
Why?
| | Fertility | 1 | 2023 | 159 | 0.190 |
Why?
| | Dilatation | 1 | 2022 | 66 | 0.190 |
Why?
| | Goals | 1 | 2023 | 169 | 0.180 |
Why?
| | Menstrual Cycle | 1 | 2022 | 132 | 0.180 |
Why?
| | Focus Groups | 1 | 2024 | 513 | 0.180 |
Why?
| | Cross-Sectional Studies | 2 | 2023 | 5419 | 0.180 |
Why?
| | Desogestrel | 1 | 2021 | 46 | 0.180 |
Why?
| | Drug Implants | 1 | 2021 | 82 | 0.180 |
Why?
| | Delayed Diagnosis | 2 | 2019 | 91 | 0.180 |
Why?
| | Hirschsprung Disease | 1 | 2022 | 87 | 0.180 |
Why?
| | Personal Satisfaction | 1 | 2023 | 206 | 0.180 |
Why?
| | Hormones | 1 | 2021 | 142 | 0.180 |
Why?
| | Colon, Sigmoid | 1 | 2021 | 20 | 0.180 |
Why?
| | Tamoxifen | 1 | 2021 | 202 | 0.170 |
Why?
| | Michigan | 1 | 2020 | 108 | 0.170 |
Why?
| | Developmental Disabilities | 1 | 2023 | 262 | 0.170 |
Why?
| | Pain | 2 | 2023 | 755 | 0.170 |
Why?
| | Curriculum | 3 | 2022 | 973 | 0.170 |
Why?
| | Virus Diseases | 1 | 2022 | 213 | 0.160 |
Why?
| | Obstetrics | 1 | 2022 | 162 | 0.160 |
Why?
| | Tertiary Care Centers | 1 | 2020 | 159 | 0.160 |
Why?
| | Laparoscopy | 1 | 2024 | 464 | 0.160 |
Why?
| | Triamcinolone | 1 | 2019 | 17 | 0.160 |
Why?
| | Clobetasol | 1 | 2019 | 7 | 0.160 |
Why?
| | Ointments | 1 | 2019 | 25 | 0.160 |
Why?
| | Dilatation, Pathologic | 1 | 2019 | 61 | 0.150 |
Why?
| | Simulation Training | 1 | 2020 | 98 | 0.150 |
Why?
| | Testosterone | 1 | 2022 | 401 | 0.150 |
Why?
| | Educational Measurement | 2 | 2020 | 280 | 0.150 |
Why?
| | Genitalia, Female | 1 | 2018 | 38 | 0.150 |
Why?
| | Diagnostic Errors | 1 | 2019 | 170 | 0.140 |
Why?
| | Ovarian Neoplasms | 1 | 2024 | 562 | 0.140 |
Why?
| | Adenocarcinoma | 1 | 2025 | 938 | 0.140 |
Why?
| | Early Detection of Cancer | 1 | 2022 | 417 | 0.140 |
Why?
| | Sex Differentiation | 1 | 2017 | 10 | 0.140 |
Why?
| | MAP Kinase Kinase Kinase 1 | 1 | 2017 | 19 | 0.140 |
Why?
| | Transition to Adult Care | 1 | 2018 | 81 | 0.130 |
Why?
| | Middle Aged | 4 | 2023 | 33225 | 0.130 |
Why?
| | Hospitals, Pediatric | 1 | 2020 | 505 | 0.130 |
Why?
| | Hemorrhage | 1 | 2021 | 720 | 0.130 |
Why?
| | Castration | 1 | 2016 | 14 | 0.130 |
Why?
| | Prophylactic Surgical Procedures | 1 | 2016 | 7 | 0.130 |
Why?
| | Postoperative Complications | 3 | 2024 | 2639 | 0.130 |
Why?
| | Surveys and Questionnaires | 3 | 2024 | 5739 | 0.130 |
Why?
| | Cysts | 1 | 2017 | 111 | 0.120 |
Why?
| | Prospective Studies | 3 | 2023 | 7572 | 0.120 |
Why?
| | Infant, Newborn | 2 | 2025 | 6031 | 0.120 |
Why?
| | Perinatal Care | 1 | 2016 | 56 | 0.120 |
Why?
| | Baths | 1 | 2015 | 14 | 0.120 |
Why?
| | Caregivers | 1 | 2023 | 870 | 0.120 |
Why?
| | Adolescent Health Services | 1 | 2016 | 71 | 0.120 |
Why?
| | Pregnancy in Adolescence | 1 | 2016 | 80 | 0.120 |
Why?
| | Abortion, Induced | 1 | 2017 | 103 | 0.120 |
Why?
| | Body Mass Index | 1 | 2024 | 2373 | 0.120 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 1480 | 0.110 |
Why?
| | Glucocorticoids | 1 | 2019 | 593 | 0.110 |
Why?
| | Infant | 2 | 2025 | 9395 | 0.100 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2016 | 255 | 0.100 |
Why?
| | Male | 7 | 2022 | 67305 | 0.100 |
Why?
| | Clinical Competence | 1 | 2020 | 1090 | 0.100 |
Why?
| | Mental Health Services | 1 | 2016 | 416 | 0.090 |
Why?
| | Patient-Centered Care | 1 | 2016 | 521 | 0.090 |
Why?
| | Patient Acceptance of Health Care | 1 | 2017 | 805 | 0.090 |
Why?
| | Aged, 80 and over | 1 | 2022 | 7593 | 0.080 |
Why?
| | Cohort Studies | 1 | 2020 | 5703 | 0.080 |
Why?
| | Mothers | 1 | 2016 | 752 | 0.080 |
Why?
| | Time Factors | 1 | 2020 | 6808 | 0.080 |
Why?
| | Vaginal Neoplasms | 1 | 2025 | 18 | 0.060 |
Why?
| | Intrauterine Device Expulsion | 1 | 2024 | 9 | 0.060 |
Why?
| | Vaccination | 2 | 2022 | 1377 | 0.050 |
Why?
| | Databases, Factual | 2 | 2019 | 1351 | 0.050 |
Why?
| | Radiology, Interventional | 1 | 2023 | 33 | 0.050 |
Why?
| | Aged | 1 | 2022 | 23800 | 0.050 |
Why?
| | Urogenital System | 1 | 2022 | 17 | 0.050 |
Why?
| | Vulva | 1 | 2022 | 24 | 0.050 |
Why?
| | Drainage | 1 | 2023 | 171 | 0.050 |
Why?
| | Single-Blind Method | 1 | 2020 | 282 | 0.040 |
Why?
| | Hydrocolpos | 1 | 2019 | 5 | 0.040 |
Why?
| | Perineum | 1 | 2019 | 32 | 0.040 |
Why?
| | Genitalia | 1 | 2019 | 30 | 0.040 |
Why?
| | Biological Variation, Population | 1 | 2018 | 21 | 0.040 |
Why?
| | United States | 3 | 2022 | 14682 | 0.040 |
Why?
| | Rectal Prolapse | 1 | 2018 | 23 | 0.040 |
Why?
| | Urologic Diseases | 1 | 2018 | 41 | 0.040 |
Why?
| | Digestive System Surgical Procedures | 1 | 2018 | 106 | 0.030 |
Why?
| | Abortifacient Agents, Steroidal | 1 | 2017 | 5 | 0.030 |
Why?
| | Dilatation and Curettage | 1 | 2017 | 11 | 0.030 |
Why?
| | Fecal Incontinence | 1 | 2018 | 86 | 0.030 |
Why?
| | Lost to Follow-Up | 1 | 2017 | 19 | 0.030 |
Why?
| | Mifepristone | 1 | 2017 | 64 | 0.030 |
Why?
| | Pregnancy Trimester, Second | 1 | 2017 | 80 | 0.030 |
Why?
| | Colorado | 2 | 2018 | 4512 | 0.030 |
Why?
| | Fellowships and Scholarships | 1 | 2020 | 303 | 0.030 |
Why?
| | Reference Values | 1 | 2018 | 816 | 0.030 |
Why?
| | Reoperation | 1 | 2019 | 573 | 0.030 |
Why?
| | Pedigree | 1 | 2017 | 514 | 0.030 |
Why?
| | Comorbidity | 1 | 2021 | 1614 | 0.030 |
Why?
| | Ultrasonography, Prenatal | 1 | 2017 | 284 | 0.030 |
Why?
| | Depression, Postpartum | 1 | 2016 | 132 | 0.030 |
Why?
| | Program Development | 1 | 2016 | 364 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2020 | 3264 | 0.020 |
Why?
| | Parenting | 1 | 2016 | 306 | 0.020 |
Why?
| | Pandemics | 1 | 2021 | 1615 | 0.020 |
Why?
| | Program Evaluation | 1 | 2016 | 889 | 0.020 |
Why?
| | Mental Health | 1 | 2016 | 716 | 0.020 |
Why?
| | Parents | 1 | 2017 | 1340 | 0.020 |
Why?
| | Physicians | 1 | 2017 | 905 | 0.020 |
Why?
| | Mutation | 1 | 2017 | 3947 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2019 | 10747 | 0.010 |
Why?
|
|
Alaniz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|